 |
 |
[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[e-drug] Metronidazole (cont)
- Subject: [e-drug] Metronidazole (cont)
- From: [email protected]
- Date: Thu, 19 Sep 2002 20:30:29 -0400 (EDT)
E-drug: Metronidazole (cont)
---------------------------------------------
As far as I know metronidazole has a very important,
possibly unique characteristic, that of not inducing antibiotic
resistance. Maybe you could look into whether this is a class effect
because if it is not I think metronidazole should be retained despite
its inconvenient treatment schedule.
Valeria
--
Dr. Valeria Frighi
Diabetes Trials Unit
Radcliffe Infirmary
Woodstock Road
Oxford OX2 6HE
UK
tel. -44-1865-228422
fax -44-1865-224584
e-mail [email protected]
--
To send a message to E-Drug, write to: [email protected]
To subscribe or unsubscribe, write to: [email protected]
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: [email protected]
Information and archives: http://www.healthnet.org/programs/edrug.html
|
